Protocols vary, but many clinics structure treatment in cycles of several weeks to a few months, with periodic reassessment to determine whether to continue, taper, or discontinue therapy
Clinical trials tested doses up to 1mg daily without significant adverse effects, but this does not mean higher doses produce better results or that exceeding researched doses is safe
Patients found to have a low serum cobalamin level in the absence of anaemia and who do not have food malabsorption or other causes of deficiency, should be tested for IFAB to clarify whether they have an early or latent presentation of pernicious anaemia
Because acarbose has limited systemic absorption, which results in minimal maternal plasma concentrations, clinically significant exposure via breast milk is not expected
If the deficiency was purely dietary, oral supplementation may be considered after initial repletion
Case Study 3: Sarahs Preventive Care Coverage Sarah, a 75-year-old Medicare beneficiary, had a routine wellness exam where her doctor identified potential symptoms of a B12 deficiency